Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Advanced Course on NTRK Gene Fusion: A New Target in Precision Treatment of Cancer 2020

ESMO-Advanced-Course-on-NTRK-Gene-Fusion-Singapore-2020-1000x250
Start date
23 Nov 2020
End date
24 Nov 2020
Location
Virtual, GMT +8
Application deadline
28 Oct 2020

The course will start at 3 pm - Singapore local time (GMT+8)​

Learning objectives

  • Acquire knowledge of the TRK family members and their roles in ontogenesis
  • Understand the mechanisms of gene fusion and the different fusion partners involved
  • Learn how TRK receptors are structured and how their activation impacts signal transduction
  • Review the epidemiology of NTRK gene fusion in human tumours
  • Understand the methodology to identify NTRK gene fusion and the challenges of testing
  • Update knowledge on the present outcome obtained with NTRK inhibitors, their toxicities and clinical management

Download the preliminary programme

Apply now!

How to apply

Application is via online form. During the application process you will be required to upload the following:

  • Your CV including a list of your publications

Application deadline

Application for the virtual course will close on 28 October 2020

Who can apply?

While this online course is primarily aimed at experienced oncologists resident in Asia, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary registration for this virtual course.

Accreditation

The programme of this virtual event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

​​Caterina Marchiò, Italy
David S. P. Tan, Singapore

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings